(19)
(11) EP 1 731 113 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
13.11.2013 Bulletin 2013/46

(45) Mention of the grant of the patent:
21.08.2013 Bulletin 2013/34

(21) Application number: 04807269.8

(22) Date of filing: 17.12.2004
(51) International Patent Classification (IPC): 
A61B 19/02(2006.01)
(86) International application number:
PCT/JP2004/018911
(87) International publication number:
WO 2005/092232 (06.10.2005 Gazette 2005/40)

(54)

Medical treatment kit

Medizinischs Behandlungskit

Kit de traitement médical

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 29.03.2004 JP 2004095061
29.09.2004 JP 2004284242

(43) Date of publication of application:
13.12.2006 Bulletin 2006/50

(73) Proprietor: Aglis Co., Ltd.
Yame-shi, Fukuoka 8340055 (JP)

(72) Inventor:
  • NAKAMURA, Hiroyuki, Aglis co., ltd.
    Yame-shi, Fukuoka 8340055 (JP)

(74) Representative: Gille Hrabal 
Patentanwälte Brucknerstrasse 20
40593 Düsseldorf
40593 Düsseldorf (DE)


(56) References cited: : 
JP-A- 9 103 465
JP-A- 2000 225 126
JP-A- 2000 271 150
JP-A- 2002 102 252
US-A- 5 163 557
US-B1- 6 372 313
 JP-A- 10 086 977
JP-A- 2000 271 150
JP-A- 2002 102 252
US-A- 4 989 733
US-A1- 2004 004 019
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).